CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma-Reference-Cited by-同舟云学术

CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma

Published:2022-12 Issue: Volume:352 Page:920-930
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Hsieh Hsin-Tzu,Huang Hsi-Chien,Chung Chieh-Wei,Chiang Cheng-Chin,Hsia Tiffaney,Wu Hsin-Fang,Huang Rui-Lin,Chiang Chi-Shiun,Wang Jane,Lu Tsai-Te,Chen Yunching

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference38 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016;Ostrom;Neuro-oncology,2019

2. Potential biomarkers and challenges in glioma diagnosis, therapy and prognosis;Kan;BMJ Neurol. Open,2020

3. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma;Cloughesy;Nat. Med.,2019

4. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial;Reardon;JAMA Oncol.,2020

5. A Randomized, Phase 3, Open-Label Study of Nivolumab Versus Temozolomide (TMZ) in Combination with Radiotherapy (RT) in Adult Patients (Pts) with Newly Diagnosed, O-6-Methylguanine DNA Methyltransferase (MGMT)-Unmethylated Glioblastoma (GBM): CheckMate-498;Sampson,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitric Oxide‐Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment;Advanced Functional Materials;2023-12-21

2. A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy;International Journal of Nanomedicine;2023-12

3. Nanoparticles and Mesenchymal Stem Cell (MSC) Therapy for Cancer Treatment: Focus on Nanocarriers and a si-RNA CXCR4 Chemokine Blocker as Strategies for Tumor Eradication In Vitro and In Vivo;Micromachines;2023-11-07

4. Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges;Macromolecular Bioscience;2023-10-22

5. Comprehensive analysis of cell-extracellular matrix protein Ras suppressor-1 in function and prognosis of gastrointestinal cancers;World Journal of Methodology;2023-09-20